...
首页> 外文期刊>Surgical Science >Postrecurrence Clinical Outcome of Patients with Stage I Epithelial Ovarian Cancer Who Underwent Fertility-Sparing Surgery Compared to Those with Radical Surgery
【24h】

Postrecurrence Clinical Outcome of Patients with Stage I Epithelial Ovarian Cancer Who Underwent Fertility-Sparing Surgery Compared to Those with Radical Surgery

机译:与根治性手术相比,保留生育力的I期上皮性卵巢癌患者的复发后临床结果

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: To examine the difference in the survival of patients with recurrent ovarian cancer who received fertility-sparing surgery (FSS) and those receiving radical surgery. Methods: Clinicopathologic data on a total of 90 patients with stage I recurrent ovarian cancer collected under the central pathological review system were subjected to survival analyses. Patients were divided into 2 groups: 1) FSS (N = 11), 2) Radical (N = 79). Results: Five-year overall survival rates of patients in the two groups were as follows: 40.8% (FSS)/44.2% (Radical), respectively. There was no significant difference in overall survival among the groups (P = 0.887). Additionally, three-year postrecurrence survival rates of patients in the two groups were 24.8% (FSS) and 25.3% (Radical) (P = 0.730). Furthermore, we accumulated 137 patients {FSS (N = 58), Radical group (N = 79)} with stage I recurrent ovarian cancer from the current study and six representative reports in the literature. Patients who experienced recurrence in the remaining ovary alone (FSS) showed a more favorable prognosis than those who had extra-ovarian site recurrence (overall survival: P = 0.021, postrecurrence survival: P = 0.069). Conclusions: Although our retrospective analysis was very preliminary, we could propose the hypothesis that patients with stage I recurrent ovarian cancer who undergo FSS may not show poorer survival rates than patients who receive radical surgery.
机译:背景:探讨接受保胎手术(FSS)和接受根治性手术的复发性卵巢癌患者生存率的差异。方法:对在中央病理检查系统下收集的总共90例I期复发性卵巢癌患者的临床病理资料进行生存分析。患者分为2组:1)FSS(N = 11),2)根治性(N = 79)。结果:两组患者的五年总生存率分别为:40.8%(FSS)/44.2%(Radical)。各组的总生存率无显着差异(P = 0.887)。此外,两组患者的三年复发生存率分别为24.8%(FSS)和25.3%(Radical)(P = 0.730)。此外,根据本研究和文献中的六篇代表性报告​​,我们收集了137例{FSS(N = 58),自由基组(N = 79)}的I期复发性卵巢癌患者。仅在剩余卵巢中复发的患者(FSS)的预后要好于卵巢外复发的患者(总生存期:P = 0.021,复发后生存期:P = 0.069)。结论:尽管我们的回顾性分析是非常初步的,但我们可以提出这样的假设:接受FSS的I期复发性卵巢癌患者的生存率可能不如接受根治性手术的患者低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号